• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAGELLAN DIAGNOSTICS, INC. LEADCARE ULTRA CONSUMABLE; LEADCARE ULTRA TEST KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAGELLAN DIAGNOSTICS, INC. LEADCARE ULTRA CONSUMABLE; LEADCARE ULTRA TEST KIT Back to Search Results
Model Number 70-8090
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/28/2014
Event Type  malfunction  
Manufacturer Narrative
Mdr 1218996-2017-00040 addendum: magellan's investigations have confirmed that extended incubation (ie overnight) of blood/treatment reagent mixtures at room temperature or incubation at high temperatures (ie, 60 c) improved test results for some blood specimens.Studies suggest the venous blood collection tube contributes to the low results as similar low results are not observed with capillary blood samples.Magellan has since determined the root cause of suppressed results with venous bloods samples to be directly related to a material change in the rubber stopper of the bd blood collection tube kit.Current labeling indicates that venous samples should not be used on the leadcare system.Same device kit from customer could not be used.The lot 1404au materials were from magellan inventory.Case number; (b)(4).Late filing is part of magellan diagnostics, inc.Response to fda's 483 issued on 29jun2017.Testing was all done on (b)(6) 2014 and patient sample results for lcu vs icp-ms (in ug/dl) were all filled under one mdr.We will now be submitting separate mdrs for each individual patient result.Results: (lcu vs icp-ms).4.3 vs 6.4 [1218996-2019-00055]; 4.6 vs 7.3 [1218996-2019-00056]; 2.1 vs 5.4 [1218996-2019-00057]; 3.5 vs 7.8 [1218996-2019-00058]; 1.8 vs 5.1; 3.9 vs 6.5 [1218996-2019-00060].
 
Event Description
Mdr 1218996-2017-00040 addendum: samples tested with leadcare ultra produced results that were low when compared to the reference method icp/ms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEADCARE ULTRA CONSUMABLE
Type of Device
LEADCARE ULTRA TEST KIT
Manufacturer (Section D)
MAGELLAN DIAGNOSTICS, INC.
101 billerica ave.
building 4
n. billerica MA 01862
Manufacturer (Section G)
MAGELLAN DIAGNOSTICS, INC.
101 billerica ave
building 4
n. billerica MA 01862
Manufacturer Contact
ivy margaret thiong'o
101 billerica ave
building 4
n. billerica, MA 01862
9783135480
MDR Report Key9356617
MDR Text Key220629196
Report Number1218996-2019-00059
Device Sequence Number1
Product Code DOF
UDI-Device Identifier00850355006024
UDI-Public00850355006024
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123563
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Administrator/Supervisor
Type of Report Initial
Report Date 11/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/21/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/25/2015
Device Model Number70-8090
Device Catalogue Number70-8090
Device Lot Number1404AU
Was Device Available for Evaluation? No
Date Manufacturer Received10/28/2014
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/25/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-